Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MFA Financial Inc MFA

Alternate Symbol(s):  MFA.PR.B | MFA.PR.C

MFA Financial, Inc. is a specialty finance company that invests in residential mortgage loans, residential mortgage-backed securities and other real estate assets. Its targeted investments include principally residential whole loans and residential mortgage securities. Its residential whole loans include purchased performing loans, purchased credit deteriorated and purchased non-performing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NYSE:MFA)

These stocks are paying 17% dividends

Tom Dyson February 26, 2010

Bullboard Posts (NYSE:MFA)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
GenevaC - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
GenevaC - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
GenevaC - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
GenevaC - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

GenevaC - May 11, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
GenevaC - May 1, 2022